We're facing the Tragedy of the Commons in this case. Drug prices are strictly regulated in Canada and the European Union. The United States of America, on the other hand, is the wild west of deregulation. Big Pharma is racing to the bottom here. If they were regulated in the U.S.A. at the same level as other industrialized countries people would have much better access to drugs that remedy their situations.
Again, here is another opportunity where the Obama Administration has buckled at the knees on what they thought was a curveball yet was a tipped pitch that they should have hit out of the park.
Why are corporate profits always put above consumer protection and consumer cost savings? Because it's profitable. Scare tactics and diversions. The drugs that would be imported are made by the same manufacturers as the drugs we have domestically. It is manifest that there are dangers associated with a drug regimen, but the safety issue isn't increased by importation of pharmaceuticals. Big Pharma gobbles up profits in the U.S. because of these pretextual reasons.
Big Pharma will not accept reform, and here is another opportunity where Obama is deciding not to honor his campaign rhetoric. Stand and deliver. There is no heavy lifting necessary on this issue.
No comments:
Post a Comment